Results 171 to 180 of about 826,925 (266)

Technology Transfer of O-(2-[18F] Fluoroethyl)-L-Tyrosine (IASOglio^®) Radiopharmaceutical. [PDF]

Pharmaceuticals (Basel)
Notaro A, Limpido S, Plougastel L, Zega A, Telleschi M, Quaglierini M, Danti A, Fiore A, Guiducci L, Poli M.   +9 more
europepmc   +1 more source

VA TECHNOLOGY TRANSFER PROGRAM RESPONDS TO COVID-19 PANDEMIC. [PDF]

Technol Innov, 2021
Duvall J, Grindle GG, Kaplan J, Marks D, Sylvers L, Patel J, Lain M, Bagay A, Chung CS, Cooper RA.   +9 more
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

How to promote university technology transfer? A configuration analysis based on technology, organization and environment framework. [PDF]

PLoS One
Wang X.
europepmc   +1 more source

Spatiotemporal characteristics and influencing factor analysis of universities' technology transfer level in China: The perspective of innovation ecosystems. [PDF]

PLoS One, 2022
Fang H, Wang J, Yang Q, Liu X, Cao L.
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

Proof-of-principle of a technology transfer of a dried blood virus neutralisation assay to a Gavi-eligible country. [PDF]

BMJ Glob Health
Obodai E, Terstappen J, Mensah JY, Versnel A, Antwi CN, Bont LJ, Cianci D, Delemarre EM, Odoom JK, van de Ven PM, Mazur NI.   +10 more
europepmc   +1 more source

Making medicines in post-colonial Ghana: State policies, technology transfer and pharmaceuticals market. [PDF]

Soc Sci Med, 2022
Pourraz J.
europepmc   +1 more source

Matrix metalloproteinase‐9 regulates cell adhesion and membrane protrusive activity of ovarian cancer cells

FEBS Open Bio, EarlyView.
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel, Sam Bennett, Natalie Ehlinger, Nelson Cook, Katelyn Marvin, Caleb L. Lines, Sam Reyes, Brooke Kirby, Shawn M. Ellerbroek   +8 more
wiley   +1 more source

Evaluation of laboratory workers competency on loop mediated isothermal amplification (LAMP) technology for malaria diagnostics: a technology transfer assessment study (LAMP-TTA) during a multi-site clinical trial. [PDF]

Malar J
Tegegne B, Kamaliddin C, Pillai DR.
europepmc   +1 more source